POSITRON EMISSION TOMOGRAPHY –
COMPUTERIZED TOMOGRAPGY
(PET-CT) PROCEDURES

POSITRON EMISSION TOMOGRAPHY –
COMPUTERIZED TOMOGRAPGY
(PET-CT) PROCEDURES

CAT cardio05

18F-FDG CARDIOLOGIC PET-CT

DESCRIPTION

Study of the metabolism of cardiac glucose, completing myocardial perfusion studies.

PREPARATION

  • Six-hour fasting.
  • Intense physical exercise must be avoided 24 hours before the study.
  • An insulin clamp or oral glucose overload must be performed.

INDICATIONS

Study of myocardial viability.

DURATION OF
PROCEDURE

2 hours.

18F-FDG CARDIOLOGIC PET-CT

DESCRIPTION

Study of the metabolism of cardiac glucose, completing myocardial perfusion studies.

PREPARATION

  • Six-hour fasting.
  • Intense physical exercise must be avoided 24 hours before the study.
  • An insulin clamp or oral glucose overload must be performed.

INDICATIONS

Study of myocardial viability.

DURATION OF PROCEDURE

2 hours.

CAT neuro02

18F-FDG NEUROLOGIC PET-CT

DESCRIPTION

Study of glucose metabolism of the brain.

PREPARATION

  • Four to six-hour fasting.
  • The patients should take the usual medication. There is the possibility of withdrawing the psychotropic drugs.
  • Diabetic patients should take their usual medication.
  • If needed, a sedation will be performed 20 minutes after the administration of FDG, preferably before images acquisition, according to the anesthesia procedure.

INDICATIONS

  • Early diagnosis and differential diagnosis of dementias.
  • Study of movement disorders, for the characterization of atypical parkinsonisms.
  • Delimitation of the epileptographic focus of interictal phase in epilepsy.
  • Evaluation of some psychiatric disorders (schizophrenia, depression, obsessive-compulsive disorder).
  • Evaluation of cranioencephalic traumatisms and cerebrovascular pathologies.

DURATION OF
PROCEDURE

30 minutes.

18F-FDG NEUROLOGIC PET-CT

DESCRIPTION

Study of glucose metabolism of the brain.

PREPARATION

  • Four to six-hour fasting.
  • The patients should take the usual medication. There is the possibility of withdrawing the psychotropic drugs.
  • Diabetic patients should take their usual medication.
  • If needed, a sedation will be performed 20 minutes after the administration of FDG, preferably before images acquisition, according to the anesthesia procedure.

INDICATIONS

  • Early diagnosis and differential diagnosis of dementias.
  • Study of movement disorders, for the characterization of atypical parkinsonisms.
  • Delimitation of the epileptographic focus of interictal phase in epilepsy.
  • Evaluation of some psychiatric disorders (schizophrenia, depression, obsessive-compulsive disorder).
  • Evaluation of cranioencephalic traumatisms and cerebrovascular pathologies.

DURATION OF PROCEDURE

30 minutes.

CAT onco03

18F-FD GONCOLOGIC PET-CT

DESCRIPTION

Study of oncologic patients.

PREPARATION

  • Fasting of at least 6 hours before performing the procedure is required. In general, it is advisable that patients take a light meal the night before the study and that they do not ingest anything until after it has been done.
  • On the day of the procedure, the patient will have to drink abundant water (0.5-1L). Juices, sugary solutions, sweets etc. are not allowed. Urine must not be retained. Intravenous glucose solutions should also interrupt at least 6 hours before the scheduled time of the procedure.
  • The patient should take his/her usual medication.
  • It is necessary to avoid doing physical exercises 2-3 days before the procedure since this could condition a high muscular uptake of the tracer.
  • Diabetic type II and hyperglycemic patients treated with oral antidiabetic medicines should take their usual medication early in the morning and preferably stay in bed at night before performing the test.
  • Type I or diabetic patients with subcutaneous/intravenous insulin therapy should take their usual medication early in the morning. To avoid possible hypoglycemia, these patients can take some light breakfast, with a minimum of 4 hours before the procedure.

INDICATIONS

  • Characterization of pancreatic masses.
  • Detection of:

    • Lung pulmonary nodules.
    • Evident tumors of unknown origin.
  • Detection of recurrences of:

    • Gliomas with high degree of malignancy.
    • Head and neck tumors.
    • Differential thyroid cancer (high TG and negative RCI).
    • Primary lung carcinoma.
    • Breast carcinoma.
    • Pancreatic carcinoma.
    • Colorectal carcinoma.
    • Ovarian cancer.
    • Malignant lymphoma.
    • Malignant melanoma.
    • Other carcinomas.
  • Staging of:

    • Malignant melanoma.
    • Locally advanced breast cancer.
    • Head and neck tumors.
    • Primary lung cancer.
    • Esophagus cancer.
    • Pancreatic cancer.
    • Colorectal cancer.
    • Malignant lymphomas.
  • Monitoring of the response to the treatment of:

    • Malignant lymphomas
    • Head and neck tumors.

DURATION OF
PROCEDURE

2-3 hours.

18F-FDG ONCOLOGIC PET-CT

DESCRIPTION

Study of oncologic patients.

PREPARATION

  • Fasting of at least 6 hours before performing the procedure is required. In general, it is advisable that patients take a light meal the night before the study and that they do not ingest anything until after it has been done.
  • On the day of the procedure, the patient will have to drink abundant water (0.5-1L). Juices, sugary solutions, sweets etc. are not allowed. Urine must not be retained. Intravenous glucose solutions should also interrupt at least 6 hours before the scheduled time of the procedure.
  • The patient should take his/her usual medication.
  • It is necessary to avoid doing physical exercises 2-3 days before the procedure since this could condition a high muscular uptake of the tracer.
  • Diabetic type II and hyperglycemic patients treated with oral antidiabetic medicines should take their usual medication early in the morning and preferably stay in bed at night before performing the test.
  • Type I or diabetic patients with subcutaneous/intravenous insulin therapy should take their usual medication early in the morning. To avoid possible hypoglycemia, these patients can take some light breakfast, with a minimum of 4 hours before the procedure.

INDICATIONS

  • Characterization of pancreatic masses.
  • Detection of:

    • Lung pulmonary nodules.
    • Evident tumors of unknown origin.
  • Detection of recurrences of:

    • Gliomas with high degree of malignancy.
    • Head and neck tumors.
    • Differential thyroid cancer (high TG and negative RCI).
    • Primary lung carcinoma.
    • Breast carcinoma.
    • Pancreatic carcinoma.
    • Colorectal carcinoma.
    • Ovarian cancer.
    • Malignant lymphoma.
    • Malignant melanoma.
    • Other carcinomas.
  • Staging of:

    • Malignant melanoma.
    • Locally advanced breast cancer.
    • Head and neck tumors.
    • Primary lung cancer.
    • Esophagus cancer.
    • Pancreatic cancer.
    • Colorectal cancer.
    • Malignant lymphomas.
  • Monitoring of the response to the treatment of:

    • Malignant lymphomas
    • Head and neck tumors.

DURATION OF PROCEDURE

2-3 hours.

CAT pet01

18F-CHOLINE PET-CT

DESCRIPTION

Study prostate cancer patients by studying the synthesis of cell membranes.

PREPARATION

  • No previous preparation is needed.
  • No fasting required.

INDICATIONS

Prostate cancer staging and follow-up.

DURATION OF
PROCEDURE

1 hour.

18F-CHOLINE PET-CT

DESCRIPTION

Study prostate cancer patients by studying the synthesis of cell membranes.

PREPARATION

  • No previous preparation is needed.
  • No fasting required.

INDICATIONS

Prostate cancer staging and follow-up.

DURATION OF PROCEDURE

1 hour.

CAT pet02

18F-DOPA PET-CT

DESCRIPTION

  • Diagnosis of diseases that degrade the presynaptic dopaminergic system.
  • Diagnosis of catecholamine-producing tumors.

PREPARATION

Four to six-hour fasting is required before the injection.

INDICATIONS

  • Pediatric diagnosis of congenital hyperinsulinism.
  • Diagnosis of neuroendocrine tumors, pheochromocytomas, neuroblastomas, paragangliomas and brain tumors.
  • Assessment of Parkinson’s disease.

DURATION OF
PROCEDURE

80 minutes.

18F-DOPA PET-CT

DESCRIPTION

  • Diagnosis of diseases that degrade the presynaptic dopaminergic system.
  • Diagnosis of catecholamine-producing tumors.

PREPARATION

Four to six-hour fasting is required before the injection.

INDICATIONS

  • Pediatric diagnosis of congenital hyperinsulinism.
  • Diagnosis of neuroendocrine tumors, pheochromocytomas, neuroblastomas, paragangliomas and brain tumors.
  • Assessment of Parkinson’s disease.

DURATION OF PROCEDURE

80 minutes.

CAT infecto01

18F-FDG PET-CT FOR THE DETECTION OF
INFLAMMATORY AND INFECTIOUS PROCESSES

DESCRIPTION

Detection of areas with inflammatory or infectious phenomena in non-soft tissues.

PREPARATION

  • 6-hour fasting.
  • Good hydration.

INDICATIONS

  • Sarcoidosis.
  • Peripheral osteomyelitis (excluding postoperative and diabetic foot osteomyelitis).
  • Suspected prosthetic infection.
  • Suspicion of spinal infection (vertebral osteomyelitis, spondylodiscitis or discitis, excluding postoperative infections).
  • Rating of classical fever of unknown origin.
  • Evaluation of metastatic infection and bacteremias.
  • Initial evaluation of vasculitis.
  • Evaluation of polycystic disease.
  • Suspected infection of intravascular devices, pacemakers and catheters.
  • Detection of opportunistic infections in patients with HIV, associated tumors or Castelman’s disease.

DURATION OF
PROCEDURE

90 minutes.

18F-FDG PET-CT FOR THE DETECTION OF
INFLAMMATORY AND INFECTIOUS PROCESSES

DESCRIPTION

Detection of areas with inflammatory or infectious phenomena in non-soft tissues.

PREPARATION

  • 6-hour fasting.
  • Good hydration.

INDICATIONS

  • Sarcoïdosi.
  • Osteomielitis perifèrica (excloent la postoperatòria i el peu diabètic).
  • Sospita d’infecció protèsica.
  • Sospita d’infecció espinal (osteomielitis vertebral, espondilodiscitis o discitis, excloent la postoperatòria).
  • Avaluació de la febre d’origen desconegut clàssica.
  • Avaluació de la infecció metastàsica i bacterièmies.
  • Avaluació inicial de les vasculitis.
  • Avaluació de malaltia poliquística.
  • Sospita d’infecció de dispositius intravasculars, marcapassos i catèters.
  • Detecció d’Infeccions oportunistes en pacients amb VIH, tumors associats o malaltia de Castelman.
  •  

DURATION OF PROCEDURE

90 minutes.

CAT pet03

18F-SODIUM FLUORIDE (18F-NaF) PET-CT

DESCRIPTION

Study of bone metabolism.

PREPARATION

  • No previous preparation is needed.
  • No fasting required.

INDICATIONS

  • Study of:

    • Primary bone tumors.
    • Bone viability.
    • Bone necrosis.
    • Other benign bone disorders.
  • Bone staging of:

    • Prostate cancer.
    • Breast cancer.
    • Other neoplastic diseases with blastic bone metastases.

DURATION OF
PROCEDURE

1 hour.

18F-SODIUM FLUORIDE (18F-NaF) PET-CT

DESCRIPTION

Study of bone metabolism.

PREPARATION

  • No previous preparation is needed.
  • No fasting required.

INDICATIONS

  • Study of:

    • Primary bone tumors.
    • Bone viability.
    • Bone necrosis.
    • Other benign bone disorders.
  • Bone staging of:

    • Prostate cancer.
    • Breast cancer.
    • Other neoplastic diseases with blastic bone metastases.

DURATION OF PROCEDURE

1 hour.

CAT pet04

68Ga-DOTATOC PET-CT

DESCRIPTION

Study of somatostatin receptor overexpression.

PREPARATION

  • Good previous hydration.
  • No fasting is required.

INDICATIONS

  • Study of gastroenteropancreatic neuroendocrine tumors.
  • Study of primary lesions, adenopathic involvement and metastatic dissemination.
  • Study of tumor extension.

DURATION OF
PROCEDURE

90 minutes.

68Ga-DOTATOC PET-CT

DESCRIPTION

Study of somatostatin receptor overexpression.

PREPARATION

  • Good previous hydration.
  • No fasting is required.

INDICATIONS

  • Study of gastroenteropancreatic neuroendocrine tumors.
  • Study of primary lesions, adenopathic involvement and metastatic dissemination.
  • Study of tumor extension.

DURATION OF PROCEDURE

90 minutes.

CAT neuro06

PET-CT FOR THE DETECTION OF AMYLOID PLAQUE

DESCRIPTION

Evaluation of presence of β-Amyloid in the brain.

PREPARATION

No previous preparation needed.

INDICATIONS

Early diagnosis and differential diagnosis of dementias by determining the presence or absence of β-Amyloid.

DURATION OF
PROCEDURE

2 to 24 hours.

PET-CT FOR THE DETECTION OF AMYLOID PLAQUE

DESCRIPTION

Evaluation of presence of β-Amyloid in the brain.

PREPARATION

No previous preparation needed.

INDICATIONS

Early diagnosis and differential diagnosis of dementias by determining the presence or absence of β-Amyloid.

DURATION OF PROCEDURE

2 to 24 hours.

CAT angio06 1

PET-CT FOR THE DIAGNOSIS OF VASCULITIS

DESCRIPTION

Early diagnosis of inflammation of medium and large-caliber blood vessels and evaluation of the extent and degree of extracranial vascular inflammation.

PREPARATION

Fasting of at least six hours before the injection is required.

INDICATIONS

Evaluation of vasculitis of large blood vessels (LBV):

  • Takayasu’a arteritis.
  • Giant cell arteritis.

DURATION OF
PROCEDURE

75 minutes.

PET-CT FOR THE DIAGNOSIS OF VASCULITIS

DESCRIPTION

Early diagnosis of inflammation of medium and large-caliber blood vessels and evaluation of the extent and degree of extracranial vascular inflammation.

PREPARATION

Fasting of at least six hours before the injection is required.

INDICATIONS

Evaluation of vasculitis of large blood vessels (LBV):

  • Takayasu’a arteritis.
  • Giant cell arteritis.

DURATION OF PROCEDURE

75 minutes.

Logo-SIMM-Largo

Josep Irla & Bosch Street, 5-7, Basement, Barcelona 08034, Catalonia, Spain
(+34) 93 204 6439, (+34) 93 205 7708 Fax (+34) 93 204 8641 info@simm.barcelona

LogosCalidadJuntos
Logo-SIMM-Largo

Josep Irla & Bosch Street, 5-7, Basement, Barcelona 08034, Catalonia, Spain
Phones (+34) 93 204 6439 & (+34) 93 205 7708 Fax (+34) 93 204 8641
E-mail info@simm.barcelona

LogosCalidadJuntos